- Home >
- Clinicals Trials >
- PLUME
Retour à la liste des essais cliniques
PLUME
A phase II, monocentric, single arm trial;evaluating the efficacy and safety of;Pembrolizumab in combination with Lenvatinib;in metastatic Uveal MElanoma patients
- Ouvert à Paris depuis le : 27/06/2022
- Public cible : Adult
- Phase : Phase II
Description de l'essai
Phase II, single-centre, single-arm study combining lenvatinib and pembrolizumab in patients with metastatic MU.;Each participant will receive the combination of pembrolizumab (for a maximum of 35 cycles) and lenvatinib until disease progression or significant toxicity.
Url of the trialInvestigateur principal
